Hey there,              

Over the past week, you have received several emails about MarketBeat All Access, but you didn’t sign up for the 30-day free trial.

I'll be honest; I was surprised to see you haven't accepted this offer. I am a little confused only because we had many people start the trial; I thought you'd be one of them. With this trial, customers have discovered and appreciated the unique advantage this service provides with its best-in-class portfolio monitoring tools and full access to MarketRank stock ratings.

So why didn't you accept this offer?
​​​​​
I took some time to think about the possible hesitation from people like you, and suddenly, it all made sense.

Yes, it is completely free to get the 30 day trial subscription, and I don't think anyone is complaining about that. However, I would assume the fear of getting credit card charges immediately after the trial ends stops so many customers in their tracks. 

We've all had at least one free trial experience with an unscrupulous marketer behind it who has made it impossible to cancel in time. And then fight us tooth and nail on the refund. No one wants to deal with that.

We don't either and that is not the way we do business!

Then again, how would you know we don't take that approach? We haven't met in person. We’re just a South Dakota-based media and research company that sends timely investment news and ideas to your inbox.

So, let's address this head on to give you the reassurance you need to start your 30-day trial

There is no risk in moving ahead with a 30-day trial of MarketBeat All Access.

Our team has spent years building best-in-class research tools and hiring the best editors to help you identify the best stock ideas for your portfolio. With your free subscription, you’ll get full access to our MarketRank ratings, top stock lists, portfolio monitoring tools, advanced research tools, and premium newsletters.

Our tools, reports, and newsletters provide you with the market commentary and financial data you need to stay on top of the market action.

We’ll show you which stocks Wall Street’s top analysts are fawning over and whether we think they’re right.

We’ll send you short-term trading alerts when we think there’s an obvious 5-day or 10-day trade to ride a wave of market news.

Best of all, our editors go the extra mile to explain the all-important "WHY" behind each trade. As in, why is the stock attractive and what is the upside potential?

If you want to discover the successful methods that my team of experts and I use to outperform the market, get started with a 30-day trial to MarketBeat All Access.

Over the next 30 days, you will get ongoing commentary and updated trades to find more ways to carve profits out of this challenging market environment.

After that, the choice is yours. Cancel if it doesn't suit your needs. Or stay on board to enjoy years of investment success.

I have removed the risk so that you can enjoy the reward. Click below to get started!

Get your 30-day trial of MarketBeat All Access here

Talk soon,

William Bushee
Vice President, MarketBeat.com


 
 
 
 
 
 
Thank you for subscribing to Insider Trades Daily, which covers the most recent insider buying and selling activity from Wall Street CEO's, CFO's, COO's and other insiders.
 
If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
 
If you no longer wish to receive email from InsiderTrades.com, you can unsubscribe.
 
© 2006-2024 MarketBeat Media, LLC.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.
 
Today's Bonus Content: 348 million Americans lives to END as we know it?